The Patent Finder

Regentis Biomaterials Ltd.

Also on record
Records under this name other than the patents Regentis Biomaterials Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Showing 1 to 6 of 6 · Back to Regentis Biomaterials Ltd.

PatentTitleStatus Expires Confidence
US 8,007,774Matrix Composed of a Naturally-Occurring Protein Backbone Cross Linked by a Synthetic Polymer and Methods of Generating and Using Same
Term ended
Term ended Dec 31, 2025 · High confidence
Term endedTerm ended Dec 31, 2025High confidence
US 8,858,925Pegylated Fibrinogen Precursor Molecule
Term ended
Ended no later than Jun 28, 2025 · Medium confidence
Term endedEnded no later than Jun 28, 2025Medium confidence
US 9,700,600Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
Term ended
Term ended Jan 5, 2025 · From the USPTO record
Term endedTerm ended Jan 5, 2025From the USPTO record
US 7,842,667Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
Term ended
Term ended Dec 15, 2024 · From the USPTO record
Term endedTerm ended Dec 15, 2024From the USPTO record
US 9,474,830Pegylated Fibrinogen Precursor Molecule
Lapsed on the fee record
Ended Oct 25, 2024 · Medium confidence
Lapsed on the fee recordEnded Oct 25, 2024Medium confidence
US 5,595,980Contraceptive compositions
Term ended
Term ended no later than Jan 21, 2017 · Low confidence
Term endedTerm ended no later than Jan 21, 2017Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited